RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.
Link T, Blohmer JU, Schmitt WD, Kuhlmann JD, Just M, Untch M, Stotzer O, Fasching PA, Thill M, Reinisch M, Schneeweiss A, Wimberger P, Seiler S, Huober J, Jackisch C, Rhiem K, Hanusch C, Sinn BV, Nekljudova V, Loibl S, Denkert C.
Link T, et al. Among authors: sinn bv.
Clin Cancer Res. 2023 Nov 14;29(22):4606-4612. doi: 10.1158/1078-0432.CCR-23-1801.
Clin Cancer Res. 2023.
PMID: 37725572